Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $17.3 million.

  • Neurogene's Non-Current Assets fell 15.43% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 15.43%. This contributed to the annual value of $19.8 million for FY2024, which is 10.88% down from last year.
  • Latest data reveals that Neurogene reported Non-Current Assets of $17.3 million as of Q3 2025, which was down 5.55% from $18.3 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Non-Current Assets ranged from a high of $22.2 million in Q4 2023 and a low of $9.7 million during Q3 2023.
  • In the last 3 years, Neurogene's Non-Current Assets had a median value of $18.9 million in 2025 and averaged $17.4 million.
  • Per our database at Business Quant, Neurogene's Non-Current Assets surged by 111.21% in 2024 and then dropped by 15.43% in 2025.
  • Quarterly analysis of 3 years shows Neurogene's Non-Current Assets stood at $22.2 million in 2023, then declined by 10.88% to $19.8 million in 2024, then fell by 15.43% to $17.3 million in 2025.
  • Its Non-Current Assets was $17.3 million in Q3 2025, compared to $18.3 million in Q2 2025 and $18.9 million in Q1 2025.